Your product is in use across NHS services. Do you know if it's working?
Market access is won on efficacy data. It is retained on real-world evidence. FloInsights gives pharma and device companies the operational evidence infrastructure they need to prove in-market value — at NHS service level, with publication-grade rigour, generated continuously.
We are the Operational Evidence Infrastructure for pharma and device companies working in NHS health systems. Our analytical capability is sovereign, built from our own longitudinal dataset, running on our own infrastructure, entirely independent of third-party AI platforms. Your engagement data is yours alone: it does not train our models, does not contribute to benchmark pools, and is not shared beyond your contracted scope unless explicitly agreed.
The problem we solve
Your therapy or device enters an NHS trust. It performs. But the data that would prove that performance, pathway timing, patient throughput, capacity impact, before and after comparison, is fragmented across EPR systems, scheduling tools and manual logs. Nobody has joined it up. Your value story exists. You just cannot see it.
That is what FloInsights does.
What we deliver
Real World Evidence Publication Grade
We extract, clean and analyse operational data from NHS clinical systems to produce retrospective and prospective real-world evidence at an international publication standard.
Our RWE covering 50,000 interventions across two 12-month cohorts was submitted to an international congress. From data extraction to submission in under three months.
Value Proposition Quantification
We translate service-level operational data into the numbers your market access and value-based procurement teams need: injection burden reduction, new patient capacity created, staff time returned, NHS cost per outcome.
Figures that support premium pricing conversations with payers independently generated from trust data, not modelled assumptions, and produced entirely within our sovereign analytical infrastructure. No third-party AI platform touches your data.
Service Sustainability Evidence
Payers and commissioners want to know that adoption is sustainable at scale, not just effective in trial conditions. FloInsights generates continuous before-and-after operational evidence across the full service arc, demonstrating that your therapy or device improves NHS service economics over time, not just patient outcomes in isolation.
Longitudinal Benchmarked Analysis
Our national data asset built across 125 sites, 12 countries and 100,000+ patients means we can contextualise your product's real-world performance against comparable services. That is a level of market intelligence that no claims database or registry can currently provide.
Case Study Example:
A leading ophthalmology therapy partner engaged FloInsights to generate real-world evidence of in-market drug performance across a major NHS service. Analysis of 50,000 interventions demonstrated a statistically significant operational improvement, exceeding microsimulation projections, reducing operational burden by 10% and creating capacity for 500 additional new patients annually. The full analysis was submitted to an international congress within three months of data extraction.
Governance built for NHS partnerships
Every FloInsights engagement operates under a UKGDPR Article 28 compliant Data Processing Agreement. The pseudonymisation decode key never leaves the trust. Our analytical models are sovereign, built and owned by FloInsights, running on our own infrastructure, with no dependency on third-party AI platforms. The data generated within your engagement belongs to your engagement alone. It does not train our models. It does not contribute to benchmark pools shared with other clients. Any broader use of engagement data requires explicit contractual agreement and separate governance sign-off. Our ICO-structured DPIA and Data Acquisition Plan are available for review by your regulatory and legal teams on request.
We have solved the information governance challenge that stalls most pharma-trust data partnerships and we have done it without compromising the data sovereignty that both your organisation and your NHS partners require.